Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages
-
Published:2022-03-28
Issue:1
Volume:19
Page:
-
ISSN:1743-422X
-
Container-title:Virology Journal
-
language:en
-
Short-container-title:Virol J
Author:
Nkone Paballo,
Loubser Shayne,
Quinn Thomas C.,
Redd Andrew D.,
Ismail Arshad,
Tiemessen Caroline T.,
Mayaphi Simnikiwe H.ORCID
Abstract
Abstract
Background
Despite multiple attempts, there is still no effective HIV-1 vaccine available. The HIV-1 polymerase (pol) gene is highly conserved and encodes cytotoxic T-lymphocyte (CTL) epitopes. The aim of the study was to characterise HIV-1 Pol CTL epitopes in mostly sample pairs obtained during early and chronic stages of infection.
Methods
Illumina deep sequencing was performed for all samples while Sanger sequencing was only performed on baseline samples. Codons under immune selection pressure were assessed by computing nonsynonymous to synonymous mutation ratios using MEGA. Minority CTL epitope variants occurring at $$\ge$$
≥
5% were detected using low-frequency variant tool in CLC Genomics. Los Alamos HIV database was used for mapping mutations to known HIV-1 CTL epitopes.
Results
Fifty-two participants were enrolled in the study. Their median age was 28 years (interquartile range: 24–32 years) and majority of participants (92.3%) were female. Illumina minority variant analysis identified a significantly higher number of CTL epitopes (n = 65) compared to epitopes (n = 8) identified through Sanger sequencing. Most of the identified epitopes mapped to reverse transcriptase (RT) and integrase (IN) regardless of sequencing method. There was a significantly higher proportion of minority variant epitopes in RT (n = 39, 60.0%) compared to IN (n = 17, 26.2%) and PR (n = 9, 13.8%), p = 0.002 and < 0.0001, respectively. However, no significant difference was observed between the proportion of minority variant epitopes in IN versus PR, p = 0.06. Some epitopes were detected in either early or chronic HIV-1 infection whereas others were detected in both stages. Different distribution patterns of minority variant epitopes were observed in sample pairs; with some increasing or decreasing over time, while others remained constant. Some of the identified epitopes have not been previously reported for HIV-1 subtype C. There were also variants that could not be mapped to reported CTL epitopes in the Los Alamos HIV database.
Conclusion
Deep sequencing revealed many Pol CTL epitopes, including some not previously reported for HIV-1 subtype C. The findings of this study support the inclusion of RT and IN epitopes in HIV-1 vaccine candidates as these proteins harbour many CTL epitopes.
Funder
National Research Foundation
Poliomyelitis Research Foundation
Discovery Foundation
National Health Laboratory Service
South African Medical Research Council
University of Pretoria
South African Department of Science and Innovation
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference62 articles.
1. Greene WC. A history of AIDS: looking back to see ahead. Eur J Immunol. 2008. https://doi.org/10.1002/eji.200737441.
2. Fauci AS, Marston HD. Ending AIDS-is an HIV vaccine necessary? N Engl J Med. 2014;370:495–8. https://doi.org/10.1056/NEJMp1313771.
3. UNAIDS [Internet]. Fact Sheet 2021 - Preliminary epidemiological estimates. 2021 [accessed July 2021]. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf.
4. UNAIDS [Internet]. Global 2019 HIV/AIDS Statistics. 2020 [accessed May 2021]. Available from: https://www.unaids.org/en/resources/documents/2020/unaids-data.
5. HSRC. The fifth South African national HIV prevalence, incidence, behaviour and communication survey, 2017: HIV impact assessment summary report. HSRC Press Cape Town; 2018.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献